Stock Events

Stock Events

C4 Therapeutics (CCCC) Q1 2025 Earnings

27FebConfirmed

Q2 2024

Q3 2024

Q4 2024

Q1 2025

-0.49

-0.42

-0.34

-0.26

Details

Expected EPS

-0.493054

Actual EPS

-0.49

Surprise EPS

0

Surprise Percent

+0.62%

Description

C4 Therapeutics (CCCC) has reported earnings of -0.49 per share for Q1 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.